Back to Andrew Huberman

Peptides: The Science, Uses & Safety | Dr. Abud Bakri

Andrew HubermanJune 1, 20262h 48m
Topics108
Trinity Stack Protocols0:00Podcast Introduction0:30BPC-157 Background1:01Safety and Receptor Framework2:01Defining Peptides3:30Receptor vs Non-Receptor Peptides5:01Starting with BPC-1576:32Discovery of BPC7:00Motivation Behind the Research8:01Hans Selye and Stress Theory9:00Administration Methods10:01Organ-Specific Peptides10:30Animal Studies on BPC-15711:30Sponsor Mentions14:31BPC-157 Effects on Regeneration15:02Interaction with Corticosteroids17:00Neurological Effects18:01Anecdotal Reports19:32Human Trials20:31BPC-157 Distribution and Detection22:15Clinical Trial Data on BPC-15723:00Geographic and Regulatory Skepticism24:01Legal Status of BPC-157 in the United States25:31Athlete Anecdote and Doping Context28:01GLP-1 Shortage and Compounding Market29:30Gray Market Peptide Sources33:30Market Demographics and Black Market Distinction39:00Injection Stigma Reduction40:30Theoretical Cancer Risk from Angiogenesis42:00Cardarine GW and Cancer Signals in Animal Data42:38BPC-157 Research Limitations and Current Status43:02BPC-157 Mechanism and Angiogenesis Effects44:31BPC-157 Patents and Pharmaceutical Development Challenges47:02Clinical Perspective on BPC-15749:01Potential Clinical Trial Endpoints for BPC-15749:32Gut Protective Effects and Personal Observations50:31Musculoskeletal Applications and Dosing Considerations53:31Personal Injury Recovery Anecdotes54:30Anecdotal Nature and Limitations56:32Regulatory and Safety Concerns1:00:02Physician Perspective and Legal Constraints1:01:33Oral Peptide Supplements and Legal Status1:03:00Physician Guidance and Compounding Pharmacies1:04:32Pinealon (EDR Tripeptide)1:07:30Mechanism of Action1:11:30Reported Effects and Safety Considerations1:16:00Epitalon and Pineal Gland Function1:19:30Bioregulator Peptides and Circadian Hormonal Restoration1:23:48Khavinson's 15-Year Longevity Study1:24:00Epitalon and Visual Pathway Research1:25:30Epitalon as Genetic Machinery Support1:27:00Historical Medical Abuses and Caution1:28:31Thymus Anatomy and Function1:29:30Thymus Removal Consequences1:30:30Thymus Role in Immune Development1:31:30Thymic Involution and Regeneration Approaches1:34:00Thymosin Alpha 1 Function and History1:35:00Personal Use of Thymosin Alpha 11:37:02Thymosin Beta 4 and TB-5001:38:00Peptide Use in Veterinary Applications1:40:00Regulatory Status of Peptides1:43:00Bioregulator Peptide Dosing1:44:30Concerns with Animal-Derived Peptides and Historical Research Setback1:45:08Thymulin Structure and Function1:46:30Thymulin's Role in Reproduction and Stress Hormones1:48:00Strategies for Increasing Thymulin1:48:32GHK-Cu Peptide Overview1:50:31Research on GHK-Cu Applications1:52:31Thymus Atrophy and Infection Recovery1:55:00Thymus Research and Clinical Gaps1:57:01Assessing Thymus Status1:59:00Clinical Application of Lymphocyte-to-Monocyte Ratio2:03:00Growth Hormone Secretagogues2:04:00Somatopause and Age-Related Hormonal Changes2:06:12Cancer Concerns and Growth Hormone2:07:00Species Variation and Longevity Data2:08:30Secretagogues as Alternatives2:09:00Physical Effects and Limitations2:10:30Personal Experience with Sermorelin2:11:30Metabolic Effects and Stacking Protocols2:13:00Trinity Stack Protocol2:14:30GHK-Cu Topical Applications2:16:00Skincare Integration and Light Therapy2:18:30GLP-1 Medications and Medical Impact2:20:30Healthcare System Context2:22:30Long-Term Considerations2:25:30Long-Term GLP-1 Use and Delivery Methods2:26:47Brain Development Concerns with High-Dose GLP-1s2:27:01Potential Cognitive and Alzheimer's Benefits2:28:00Training-Wheel Approach to GLP-1 Therapy2:28:31Mechanisms Behind Reported Cognitive Side Effects2:29:00Effects on Alcohol Cravings and Dopaminergic Signaling2:30:00Post-GLP-1 Clinical Reality2:30:30Leptin Sensitivity, Fertility, and Energy Status2:31:01Leptin Threshold and Puberty Onset2:32:01Personal Experience with Compounded GLP-12:32:32Retatrutide Market Potential and Patent Strategy2:34:00Biologic Classification and Patent Duration2:35:00Compounding Implications and Regulatory Shifts2:35:31Peptide Definition and Nomenclature Challenges2:37:00Endometriosis, Fibroids, and Reproductive Health2:39:30Neurological and Psychological Effects2:40:31Sourcing Peptides Safely2:42:30Closing Remarks2:44:32Huberman Lab Social Media and Newsletter Resources2:47:19Neural Network Newsletter2:47:30How to Subscribe2:48:00Closing Remarks2:48:00
In a Nutshell

Dr. Abud Bakri explains that peptides like BPC-157, Pinealon, Epitalon, GHK-Cu, and thymosin variants show promising regenerative, neuroprotective, and immune-modulating effects in animal studies and anecdotal human use, but most lack robust human trials, known receptors, or established safety data such as LD50 values. Regulatory status is shifting—BPC-157 was recently removed from the FDA's "do not compound" list but remains unapproved—while compounding pharmacies, research-chemical sites, and gray-market sources create inconsistent quality and legal risks for users. The most practical takeaway is that peptides require physician oversight, lab monitoring, and foundational health practices first, as stacking them (e.g., GLP-1s + growth hormone secretagogues + androgens) can accelerate fat loss and recovery but carries unknown long-term risks, especially for cancer, hormonal disruption, and sourcing contamination.

AI-Generated Notes

These notes were generated by AI and may contain inaccuracies.

People are now stacking their GLP-1 as their insulin sensitivity tool, their growth hormone or their GHR, and their androgen modulation therapies as this trinity stack to get very fit and very healthy quickly. A lot of transformations seen in CEOs and celebrities use a combination of those three things. TRT plus peptide or retatrutide, then using a growth hormone modulation whether growth hormone or tesamorelin. People lose a lot of fat and gain a lot of muscle in short amounts of time.

Welcome to the Huberman Lab podcast where science and science-based tools for everyday life are discussed. Andrew Huberman is a professor of neurobiology and ophthalmology at Stanford School of Medicine. Today's guest is Dr. Abu Bakri, an internal medicine physician extremely knowledgeable on the science and use of peptides. Peptides discussed include FDA-approved peptides such as the GLP agonists (Ozempic, Mounjaro, and retatrutide) as well as peptides such as body protection compound 157 or BPC-157.

BPC-157 has a very long history of being used in humans for gut health and tissue repair. There are many interesting studies in animals supporting its potential use in humans, but a minimum of formal studies in humans (one). Growth hormone secretagogues like tesamorelin, MK-677 and others are discussed. GHK copper is used to promote collagen synthesis and repair for aesthetic reasons like improving skin and hair. Peptides studied for DNA repair and longevity like epitalon and pinealon have also been touted to improve REM sleep and cognitive function.

Sign in to read the full notes

Get access to AI-generated notes, topic timestamps, and more.